Related Experiment Video

Updated: Aug 29, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Trials of newer approaches to anticoagulation in atrial fibrillation

Howard A Cooper1

  • 1Division of Cardiology, Washington Hospital Center, Washington DC 20010, USA. howard.a.cooper@medstar.net

Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|January 24, 2004
PubMed

Insights

Atrial fibrillation (AF) increases stroke risk in older adults. While warfarin is effective, new anticoagulation and non-drug therapies are emerging to improve stroke prevention.

Area of Science:

  • Cardiology
  • Geriatrics
  • Neurology

Background:

  • Atrial fibrillation (AF) is a growing epidemic, particularly in aging populations.
  • Stroke is a major complication of AF, with risk significantly increasing with age.
  • Warfarin anticoagulation effectively reduces stroke risk but presents clinical challenges due to its pharmacokinetics and narrow therapeutic window.

Purpose of the Study:

  • To review the current landscape of stroke prevention in atrial fibrillation.
  • To discuss the limitations of warfarin therapy.
  • To highlight emerging novel anticoagulation and non-pharmacological approaches for stroke risk reduction.

Main Methods:

  • Literature review of clinical trials and studies on atrial fibrillation and stroke prevention.
  • Analysis of warfarin's efficacy and limitations.
  • Overview of ongoing research into new antiplatelet agents, direct thrombin inhibitors, and non-pharmacological interventions.

Main Results:

  • Warfarin has proven efficacy in reducing stroke risk in AF patients.
  • Challenges in warfarin management include complex pharmacokinetics and a narrow therapeutic window.
  • Novel anticoagulants and non-pharmacological strategies show promise for future stroke prevention.

Conclusions:

  • Despite warfarin's effectiveness, its clinical use is complex.
  • Emerging anticoagulation therapies and non-pharmacological methods may offer improved stroke prevention in atrial fibrillation.
  • These advancements have the potential to significantly alter the management of AF-related stroke risk.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...